Imagion Biosystems Limited Share Price
Equities
IBX
AU000000IBX6
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -9.76% | -.--% | -79.15% |
02-29 | Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-15 | Imagion Biosystems CEO Resigns | MT |
Sales 2021 | 2.86M 1.87M 149M | Sales 2022 | 3.07M 2.01M 161M | Capitalization | 26.91M 17.58M 1.41B |
---|---|---|---|---|---|
Net income 2021 | -6M -3.92M -314M | Net income 2022 | -9M -5.88M -471M | EV / Sales 2021 | 25.2 x |
Net cash position 2021 | 13.35M 8.72M 698M | Net Debt 2022 | 158K 103K 8.28M | EV / Sales 2022 | 8.81 x |
P/E ratio 2021 |
-12.7
x | P/E ratio 2022 |
-2.67
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 91.86% |
1 day | -9.76% | ||
1 month | -8.64% | ||
3 months | -58.89% | ||
6 months | -85.77% | ||
Current year | -79.15% |
Managers | Title | Age | Since |
---|---|---|---|
Geoff Hollis
DFI | Director of Finance/CFO | - | 07/12/20 |
Robert Proulx
CHM | Chairman | 66 | - |
Carmen Soikowski
COO | Chief Operating Officer | - | 31/10/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Ludvigson
BRD | Director/Board Member | 74 | 07/03/17 |
Robert Proulx
CHM | Chairman | 66 | - |
Michael Harsh
BRD | Director/Board Member | 69 | 27/02/17 |
1st Jan change | Capi. | |
---|---|---|
-79.15% | 1.58M | |
-12.91% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.78% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-18.10% | 682M | |
-7.14% | 716M |
- Stock Market
- Equities
- IBX Stock